Sunnetcioglu, M.Karadas, S.Aslan, M.Ceylan, M.R.Demir, H.Oncu, M.R.Aypak, C.2025-05-102025-05-1020141234-101010.12659/MSM.8904722-s2.0-84904056060https://doi.org/10.12659/MSM.890472https://hdl.handle.net/20.500.14720/4830Background: Adenosine deaminase (ADA) activity has been discovered in several inflammatory conditions; however, there are no data associated with cutaneous anthrax. The aim of this study was to investigate serum ADA activity in patients with cutaneous anthrax. Material/Methods: Sixteen patients with cutaneous anthrax and 17 healthy controls were enrolled. We measured ADA activity; peripheral blood leukocyte, lymphocyte, neutrophil, and monocyte counts; erythrocyte sedimentation rate; and C reactive protein levels. Results: Serum ADA activity was significantly higher in patients with cutaneous anthrax than in the controls (p<0.001). A positive correlation was observed between ADA activity and lymphocyte counts (r=0.589, p=0.021) in the patient group. Conclusions: This study suggests that serum ADA could be used as a biochemical marker in cutaneous anthrax. © Med Sci Monit, 2014.eninfo:eu-repo/semantics/openAccessAdenosine Deaminase - Diagnostic UseAnthrax - DiagnosisDiagnosisArticle20N/AQ11151115424997584WOS:000339323900001